Search research articles
Contact Us
Filters
Showing results (171-180 of 8,369) with videos related to
Page
of 837
Sort By:
Drugs
|
June 10, 2017
Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal
Maurizio de Martino, Alberto Chiarugi, Attilio Boner, et al.
Drugs
|
June 14, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Drugs
|
June 15, 2017
Targeting the PGD<sub>2</sub>/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives
Maciej Kupczyk, Piotr Kuna
Drugs
|
June 3, 2017
Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
David A Schoenfeld
Drugs
|
June 3, 2017
The Whole Price of Vancomycin: Toxicities, Troughs, and Time
Meghan N Jeffres
Drugs
|
June 1, 1985
Adverse neuropsychiatric effects of anticonvulsant drugs
E H Reynolds, M R Trimble
Drugs
|
October 23, 2021
Correction to: Sotorasib: First Approval
Hannah A Blair
Drugs
|
October 27, 2021
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Eduardo Mysler, Valderilio Feijó Azevedo, Silvio Danese, et al.
Drugs
|
February 3, 2022
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Julie K K Vishram-Nielsen, Daniela Tomasoni, Finn Gustafsson, et al.
Drugs
|
February 8, 2022
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M Burnette, Steven J Nieto, Erica N Grodin, et al.
Page
of 837
Search research articles
Search
Showing results (171-180 of 8,369) with videos related to
Sort By:
Page
of 837
Drugs
|
June 10, 2017
Working Towards an Appropriate Use of Ibuprofen in Children: An Evidence-Based Appraisal
Maurizio de Martino, Alberto Chiarugi, Attilio Boner, et al.
Drugs
|
June 14, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects
Shubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Drugs
|
June 15, 2017
Targeting the PGD<sub>2</sub>/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives
Maciej Kupczyk, Piotr Kuna
Drugs
|
June 3, 2017
Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
David A Schoenfeld
Drugs
|
June 3, 2017
The Whole Price of Vancomycin: Toxicities, Troughs, and Time
Meghan N Jeffres
Drugs
|
June 1, 1985
Adverse neuropsychiatric effects of anticonvulsant drugs
E H Reynolds, M R Trimble
Drugs
|
October 23, 2021
Correction to: Sotorasib: First Approval
Hannah A Blair
Drugs
|
October 27, 2021
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Eduardo Mysler, Valderilio Feijó Azevedo, Silvio Danese, et al.
Drugs
|
February 3, 2022
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
Julie K K Vishram-Nielsen, Daniela Tomasoni, Finn Gustafsson, et al.
Drugs
|
February 8, 2022
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M Burnette, Steven J Nieto, Erica N Grodin, et al.
Page
of 837